Chemokines in Allergy
Saved in:
| Published in | Japanese Journal of Clinical Chemistry Vol. 33; no. 2; pp. 79 - 89 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Japanese |
| Published |
Japan Society of Clinical Chemistry
2004
一般社団法人 日本臨床化学会 |
| Online Access | Get full text |
| ISSN | 0370-5633 2187-4077 |
| DOI | 10.14921/jscc1971b.33.2_79 |
Cover
| Author | Kanda, Akira |
|---|---|
| Author_FL | 神田 晃 |
| Author_FL_xml | – sequence: 1 fullname: 神田 晃 |
| Author_xml | – sequence: 1 fullname: Kanda, Akira organization: Department of Clinical and Laboratory Medicine, Akita University School of Medicine |
| BackLink | https://cir.nii.ac.jp/crid/1390001204910025600$$DView record in CiNii |
| BookMark | eNo9j71PwzAUxC1UJELpyMLUgTXhPT8ntscS8SVVYoHZcpyX1iFNUZKl_z2tirrcDffT6e5WzPp9z0I8IGSorMSndgwBrcYqI8qk0_ZKJBKNThVoPRMJkIY0L4huxGIcYwWgANAWJhH35ZZ3-5_Y87iM_XLVdTxsDnfiuvHdyIt_n4vv15ev8j1df759lKt12krMp5QoUKOlQmmM8WC4blThqxwZK6Pq2tpQFxLRciAsAlVgjCLJKH2l6pxpLh7PvX2MLsSTIlk4jpOgLALIvAA4Ys9nrB0nv2H3O8SdHw7OD1MMHbvLf0fk5Em0vYRh6wfHPf0BU5pUhg |
| ContentType | Journal Article |
| Copyright | Japan Society of Clinical Chemistry |
| Copyright_xml | – notice: Japan Society of Clinical Chemistry |
| DBID | RYH |
| DOI | 10.14921/jscc1971b.33.2_79 |
| DatabaseName | CiNii Complete |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | 好酸球関連ケモカインを中心に アレルギーとケモカイン |
| DocumentTitle_FL | アレルギーとケモカイン |
| EISSN | 2187-4077 |
| EndPage | 89 |
| ExternalDocumentID | 130003357135 article_jscc1971b_33_2_33_79_article_char_en |
| GroupedDBID | --- ALMA_UNASSIGNED_HOLDINGS JSF KQ8 OK1 RJT RYH |
| ID | FETCH-LOGICAL-j215t-33c3f72412888a08edf46ab51e1b84dd99cd62119ec316c3b088432e12ab4d5e3 |
| ISSN | 0370-5633 |
| IngestDate | Thu Jun 26 23:45:53 EDT 2025 Wed Sep 03 06:29:44 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 2 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j215t-33c3f72412888a08edf46ab51e1b84dd99cd62119ec316c3b088432e12ab4d5e3 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jscc1971b/33/2/33_79/_article/-char/en |
| PageCount | 11 |
| ParticipantIDs | nii_cinii_1390001204910025600 jstage_primary_article_jscc1971b_33_2_33_79_article_char_en |
| PublicationCentury | 2000 |
| PublicationDate | 2004-00-00 |
| PublicationDateYYYYMMDD | 2004-01-01 |
| PublicationDate_xml | – year: 2004 text: 2004-00-00 |
| PublicationDecade | 2000 |
| PublicationTitle | Japanese Journal of Clinical Chemistry |
| PublicationTitleAlternate | Japanese Journal of Clinical Chemistry |
| PublicationTitle_FL | 臨床化学 Japanese Journal of Clinical Chemistry |
| PublicationYear | 2004 |
| Publisher | Japan Society of Clinical Chemistry 一般社団法人 日本臨床化学会 |
| Publisher_xml | – name: Japan Society of Clinical Chemistry – name: 一般社団法人 日本臨床化学会 |
| References | 56) Fujisawa T, et al.: Chemokine production by BEAS-2 B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by Th 2-and Th 1-derived cytokine, J Allergy Clin Immunol, 105: 126-133, 2000. 26) Teran LM, et al: Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways, J Immunol, 157: 1806-1812, 1996. 39) Fukagawa K, et aL: Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage, J Allergy Clin Immunol, 103: 1220-1221, 1999. 20) Adachi T, et al.: Myosin light chain kinase mediates eosinophil chemotaxis in a mitogenactivated protein kinase-dependent manner, J Allergy Clin Immunol, 111: 113-116, 2003. 11) 茄原順一, 山田佳之, 本田耕平: アレルギー疾患とケモカイン, 炎症と免疫, 8: 288-96, 2000. 61) Kampen GT, et al.: Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK 2 and p 38 mito gen-activated protein kinases, Blood, 15: 1911-1917, 2000. 23) Chihara J, et al.: Priming effect of RANTES on eosinophil oxidative metabolism, Allergy, 53: 1178-1182, 1998. 3) Gleich GJ, Adolphson CR: The eosinophil leukocyte, Adv Immunol, 39: 177-253, 1986. 47) Yoshimura T, et al.: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines, Proc Natl Acad Sci USA, 84: 9233-9237, 1987. 9) Teran LM: CCL chemokines and asthma, Immunol Today, 21: 235-242, 2000. 31) Ponath PD, et al: Cloning of the human eosinophil chemoattractant, eotaxin, Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils, J Clin Invest, 97: 604-612, 1996. 34) Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia, Nat Med, 2: 449-456, 1996. 48) Middleton J, et al.: Transcytosis and surface presentation IL-8 by venular endothelia l cells, Cell, 91: 385-395, 1997. 54) Pan J, et al: A novel chemokine ligand for CCR 10 and CCR 3 expressed by epithelial cells in mucosal tissues, J Immunol, 165: 2943-2949, 2000. 7) Yoshie O, Imai T, Nomiyama H: Chemokines in immunity, Adv Immunol, 78: 57-110, 2001. 24) Alam R, et al.: RANTES is a chemotactic and activating factor for human eosinophils, J Immunol, 150: 3442-3448, 1993. 2) Oyamada H, et al.: CCR 3 mRNA expression in bronchial epithelial cells and various cells in allergic inflammation, Int Arch Allergy Immunol, 120: 45-47, 1999. 30) Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS: Cloning, expression, and characterization of the human eosinophil eotaxin receptor, J Exp Med, 183: 2349-2354, 1996. 21) Kameyoshi Y, et al.: Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils, J Exp Med, 176: 587-592, 1992. 43) Cuvelier SL, Patel KD: Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3, J Exp Med, 194: 1699-1709, 2001. 44) Ying S, et al: Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics, J Immunol, 163: 6321-6329, 1999. 19) Adachi T, et al: The functional role of Rho and Rho-associated coiled-coil forming protein kinase in eotaxin signaling of eosinophils, J Immunol, 167: 4609-4615, 2001. 46) Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM: Release of RANTE S, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge, Am J Respir Crit Care Med, 156: 1377-1383, 1997. 58) Saunders J, Tarby CM: Opportunities for novel therapeutic agents acting at chemokine receptors, Drug Discov Today, 4: 80-92, 1999. 36) 茄原順一, 萱場広之, 本田耕平: ケモカインとアレルギー, 好酸球におけるシグナル伝達機構, 細胞工学, 17: 1067-1075, 1998. 25) Kakazu T, et al.: Effect of RANTES on intracellular expression of EG 2 antigen in eosinophil, Int Arch Allergy Immunol, 108: S43-S44, 1995. 45) Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA: RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes, J Exp Med, 176: 1489-1495, 1992. 52) Nagase H, et al.: Expression of CXCR 4 in eosinophils: functional analyses and cytokine-mediated regulation, J Immunol, 16 4: 5935-5943, 2000. 35) Mochizuki M, Bartels J, Mallet AI, Christophers E, Schroder JM: IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy, J Immunol, 160: 60-68, 1998. 27) Chihara J, et al.: Elevation of the plasma level of RANTES during asthma attacks, J Allergy Clin Immunol, 100: S52-S55, 1997. 37) Nakamura H, Weiss ST, Israel E, Luster AD, Drazen JM, Lilly CM: Eotaxin and impaired lung function in asthma, Am J Respir Crit Care Med, 160: 1952-1956, 1999. 55) Loetscher P, et al.: The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP-10, are natural antagonists for CCR 3, J Bio Chem, 276: 2986-2991, 2001. 42) Kitamura M, et al.: Molecular cloning of novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3, J Biol Chem, 274: 27975-27980, 1999. 5) 茆原順一: 好酸球の分子生物学, 医学のあゆみ, 170: 66-72, 1994 29) Jose PJ, et al.: Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation, J Exp Med, 179: 881-887, 1994. 28) Chihara J, Yamada H, Takamura E, Yoshino K, Nakajima S: Possible presence of RANTES in tears of patients with allergic conjunctivitis, Int Arch Allergy Immunol, 106: 428, 1995. 32) Lilly CM, et al.: Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids, J Clin Invest, 99: 1767-1773, 1997. 1) Cui CH, et al.: The role of mitogen-activated protein kinases in eotaxin-induced cytokine production from bronchial epithelial cells, Am J Respir Cell Mol Biol, 27: 329-335, 2002. 50) Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T: Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science, 261: 600-603, 1993. 10) Mantovani A: The chemokine system: redundancy for robust outputs, Immunol To day, 20: 254-257, 1999. 59) Gonzalo JA, et al.: The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness, J Exp Med, 188: 157-167, 1998. 53) Wang W, et al.: Identification of a novel chemokine (CCL 28), which binds CC R 10 (GPR 2), J Bio Chem, 275: 22313-22323, 2000. 22) Kakazu T, Chihara J, Saito A, Nakajima S: Effect of RANTES on eosinophil adhesion to plates coated with recombinant soluble intercellular adhesion molecule-1 and expression of beta 2-integrin adhesion molecules on eosinophils, Int Arch Allergy Immunol, 108: S9-S11, 1995. 18) Akira K, et al.: Red Blood Cells Regulate Eosinophil Chemotaxis by Scavenging RANTES Secreted from Endothelial Cells, Clin Exp Allergy (in press 2004). 40) Yawalkar N, et al.: Enhanced expression of eotaxin and CCR 3 in atopic dermatitis, J Invest Dermatol, 113: 43-48, 1999. 16) Schall TJ, Bacon K, Toy KJ, Goeddel DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES, Nature, 347: 669-671, 1990. 12) 茄原順一, 植木重治, 山田佳之: 炎症関連分子-好酸球, 接着分子, ケモカインなど, アレルギー科, 8: 24-31, 1999. 49) Ulfman LH, Joosten DP, van der Linden JA, Lammers JW, Zwaginga JJ, Koenderman L: IL-8 induces a transient arrest of rolling eosinophils on human endothelial cells, J Immunol, 166: 588-595, 2001. 8) Lukacs NW: Role of chemokines in the pathogenesis of asthma, Nat Rev Immunol, 1: 108-116, 2001. 51) Nagasawa T, Kikutani H, Kishimoto T: Molecular cloning and structure of a pre-B-cell growth-stimulating factor, Proc Natl Acad Sci USA, 91: 2305-2309, 1994. 15) Premack BA, Schall TJ: Chemokine receptors, Gateway to inflammation and infection Nat Med, 2: 1174-1178, 1996. 38) Yamada H, et al.: Eotaxin in induced sputum of asthmatics: relationship with eosinophil s and eosinophil cationic protein in sputum, Allergy, 55: 392-397, 2000. 17) Darbonne WC, et al: Red blood cells are a sink for interleukin 8, a leukocyte chemotaxis, J Clin Invest, 88: 1362-1369, 1991. 41) Forssmann U, et al.: Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR 3, and acts like eotaxin on human eosinophil and basophil leukocytes, J Exp Med, 185: 2171-2176, 1997. 57) Leckie MJ, et al.: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, an d the late asthmatic response, Lancet, 356: 2144-2148, 2000. 14) Horuk R: Chemokine receptors and HIV-1: the fusion of two major research fields, Immunol Today, 20: 89-94, 1999. 4) 茆原順一: 好酸球顆粒蛋白, Current Therapy, 17: 451-457, 1999. 13) Yamada H, et al.: RANTES mRNA expression in skin and colon of patients with a topic dermatitis, Int Arch Allergy Immunol, 111 Supp l, 1: 19-21, 1996. 60) Boehme SA, Sullivan SK, Bacon KB: Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration, J Immunol, 163: 1611-1618, 1999. 33) Teran LM, et al.: Th 1-and Th 2-type cytokines regulate the expression and production of eotaxin and RANTES by human fibroblast, Am J Respir Cell Mol Biol, 20: 1952-1956, 1999. 6) Capron M: Eosinophils in disease; receptors and mediators in hypersensitivity, Clin Exp Allergy, 19: 3-8, 1989. |
| References_xml | – reference: 21) Kameyoshi Y, et al.: Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils, J Exp Med, 176: 587-592, 1992. – reference: 29) Jose PJ, et al.: Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation, J Exp Med, 179: 881-887, 1994. – reference: 6) Capron M: Eosinophils in disease; receptors and mediators in hypersensitivity, Clin Exp Allergy, 19: 3-8, 1989. – reference: 3) Gleich GJ, Adolphson CR: The eosinophil leukocyte, Adv Immunol, 39: 177-253, 1986. – reference: 34) Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia, Nat Med, 2: 449-456, 1996. – reference: 10) Mantovani A: The chemokine system: redundancy for robust outputs, Immunol To day, 20: 254-257, 1999. – reference: 14) Horuk R: Chemokine receptors and HIV-1: the fusion of two major research fields, Immunol Today, 20: 89-94, 1999. – reference: 28) Chihara J, Yamada H, Takamura E, Yoshino K, Nakajima S: Possible presence of RANTES in tears of patients with allergic conjunctivitis, Int Arch Allergy Immunol, 106: 428, 1995. – reference: 15) Premack BA, Schall TJ: Chemokine receptors, Gateway to inflammation and infection Nat Med, 2: 1174-1178, 1996. – reference: 58) Saunders J, Tarby CM: Opportunities for novel therapeutic agents acting at chemokine receptors, Drug Discov Today, 4: 80-92, 1999. – reference: 19) Adachi T, et al: The functional role of Rho and Rho-associated coiled-coil forming protein kinase in eotaxin signaling of eosinophils, J Immunol, 167: 4609-4615, 2001. – reference: 32) Lilly CM, et al.: Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids, J Clin Invest, 99: 1767-1773, 1997. – reference: 7) Yoshie O, Imai T, Nomiyama H: Chemokines in immunity, Adv Immunol, 78: 57-110, 2001. – reference: 54) Pan J, et al: A novel chemokine ligand for CCR 10 and CCR 3 expressed by epithelial cells in mucosal tissues, J Immunol, 165: 2943-2949, 2000. – reference: 31) Ponath PD, et al: Cloning of the human eosinophil chemoattractant, eotaxin, Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils, J Clin Invest, 97: 604-612, 1996. – reference: 55) Loetscher P, et al.: The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP-10, are natural antagonists for CCR 3, J Bio Chem, 276: 2986-2991, 2001. – reference: 49) Ulfman LH, Joosten DP, van der Linden JA, Lammers JW, Zwaginga JJ, Koenderman L: IL-8 induces a transient arrest of rolling eosinophils on human endothelial cells, J Immunol, 166: 588-595, 2001. – reference: 2) Oyamada H, et al.: CCR 3 mRNA expression in bronchial epithelial cells and various cells in allergic inflammation, Int Arch Allergy Immunol, 120: 45-47, 1999. – reference: 39) Fukagawa K, et aL: Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage, J Allergy Clin Immunol, 103: 1220-1221, 1999. – reference: 23) Chihara J, et al.: Priming effect of RANTES on eosinophil oxidative metabolism, Allergy, 53: 1178-1182, 1998. – reference: 13) Yamada H, et al.: RANTES mRNA expression in skin and colon of patients with a topic dermatitis, Int Arch Allergy Immunol, 111 Supp l, 1: 19-21, 1996. – reference: 20) Adachi T, et al.: Myosin light chain kinase mediates eosinophil chemotaxis in a mitogenactivated protein kinase-dependent manner, J Allergy Clin Immunol, 111: 113-116, 2003. – reference: 33) Teran LM, et al.: Th 1-and Th 2-type cytokines regulate the expression and production of eotaxin and RANTES by human fibroblast, Am J Respir Cell Mol Biol, 20: 1952-1956, 1999. – reference: 48) Middleton J, et al.: Transcytosis and surface presentation IL-8 by venular endothelia l cells, Cell, 91: 385-395, 1997. – reference: 17) Darbonne WC, et al: Red blood cells are a sink for interleukin 8, a leukocyte chemotaxis, J Clin Invest, 88: 1362-1369, 1991. – reference: 60) Boehme SA, Sullivan SK, Bacon KB: Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration, J Immunol, 163: 1611-1618, 1999. – reference: 25) Kakazu T, et al.: Effect of RANTES on intracellular expression of EG 2 antigen in eosinophil, Int Arch Allergy Immunol, 108: S43-S44, 1995. – reference: 53) Wang W, et al.: Identification of a novel chemokine (CCL 28), which binds CC R 10 (GPR 2), J Bio Chem, 275: 22313-22323, 2000. – reference: 22) Kakazu T, Chihara J, Saito A, Nakajima S: Effect of RANTES on eosinophil adhesion to plates coated with recombinant soluble intercellular adhesion molecule-1 and expression of beta 2-integrin adhesion molecules on eosinophils, Int Arch Allergy Immunol, 108: S9-S11, 1995. – reference: 43) Cuvelier SL, Patel KD: Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3, J Exp Med, 194: 1699-1709, 2001. – reference: 50) Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T: Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science, 261: 600-603, 1993. – reference: 40) Yawalkar N, et al.: Enhanced expression of eotaxin and CCR 3 in atopic dermatitis, J Invest Dermatol, 113: 43-48, 1999. – reference: 1) Cui CH, et al.: The role of mitogen-activated protein kinases in eotaxin-induced cytokine production from bronchial epithelial cells, Am J Respir Cell Mol Biol, 27: 329-335, 2002. – reference: 38) Yamada H, et al.: Eotaxin in induced sputum of asthmatics: relationship with eosinophil s and eosinophil cationic protein in sputum, Allergy, 55: 392-397, 2000. – reference: 56) Fujisawa T, et al.: Chemokine production by BEAS-2 B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by Th 2-and Th 1-derived cytokine, J Allergy Clin Immunol, 105: 126-133, 2000. – reference: 57) Leckie MJ, et al.: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, an d the late asthmatic response, Lancet, 356: 2144-2148, 2000. – reference: 37) Nakamura H, Weiss ST, Israel E, Luster AD, Drazen JM, Lilly CM: Eotaxin and impaired lung function in asthma, Am J Respir Crit Care Med, 160: 1952-1956, 1999. – reference: 9) Teran LM: CCL chemokines and asthma, Immunol Today, 21: 235-242, 2000. – reference: 42) Kitamura M, et al.: Molecular cloning of novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3, J Biol Chem, 274: 27975-27980, 1999. – reference: 12) 茄原順一, 植木重治, 山田佳之: 炎症関連分子-好酸球, 接着分子, ケモカインなど, アレルギー科, 8: 24-31, 1999. – reference: 36) 茄原順一, 萱場広之, 本田耕平: ケモカインとアレルギー, 好酸球におけるシグナル伝達機構, 細胞工学, 17: 1067-1075, 1998. – reference: 16) Schall TJ, Bacon K, Toy KJ, Goeddel DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES, Nature, 347: 669-671, 1990. – reference: 27) Chihara J, et al.: Elevation of the plasma level of RANTES during asthma attacks, J Allergy Clin Immunol, 100: S52-S55, 1997. – reference: 45) Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA: RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes, J Exp Med, 176: 1489-1495, 1992. – reference: 46) Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM: Release of RANTE S, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge, Am J Respir Crit Care Med, 156: 1377-1383, 1997. – reference: 30) Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS: Cloning, expression, and characterization of the human eosinophil eotaxin receptor, J Exp Med, 183: 2349-2354, 1996. – reference: 47) Yoshimura T, et al.: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines, Proc Natl Acad Sci USA, 84: 9233-9237, 1987. – reference: 59) Gonzalo JA, et al.: The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness, J Exp Med, 188: 157-167, 1998. – reference: 51) Nagasawa T, Kikutani H, Kishimoto T: Molecular cloning and structure of a pre-B-cell growth-stimulating factor, Proc Natl Acad Sci USA, 91: 2305-2309, 1994. – reference: 4) 茆原順一: 好酸球顆粒蛋白, Current Therapy, 17: 451-457, 1999. – reference: 52) Nagase H, et al.: Expression of CXCR 4 in eosinophils: functional analyses and cytokine-mediated regulation, J Immunol, 16 4: 5935-5943, 2000. – reference: 8) Lukacs NW: Role of chemokines in the pathogenesis of asthma, Nat Rev Immunol, 1: 108-116, 2001. – reference: 61) Kampen GT, et al.: Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK 2 and p 38 mito gen-activated protein kinases, Blood, 15: 1911-1917, 2000. – reference: 5) 茆原順一: 好酸球の分子生物学, 医学のあゆみ, 170: 66-72, 1994 – reference: 26) Teran LM, et al: Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways, J Immunol, 157: 1806-1812, 1996. – reference: 41) Forssmann U, et al.: Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR 3, and acts like eotaxin on human eosinophil and basophil leukocytes, J Exp Med, 185: 2171-2176, 1997. – reference: 11) 茄原順一, 山田佳之, 本田耕平: アレルギー疾患とケモカイン, 炎症と免疫, 8: 288-96, 2000. – reference: 24) Alam R, et al.: RANTES is a chemotactic and activating factor for human eosinophils, J Immunol, 150: 3442-3448, 1993. – reference: 44) Ying S, et al: Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics, J Immunol, 163: 6321-6329, 1999. – reference: 18) Akira K, et al.: Red Blood Cells Regulate Eosinophil Chemotaxis by Scavenging RANTES Secreted from Endothelial Cells, Clin Exp Allergy (in press 2004). – reference: 35) Mochizuki M, Bartels J, Mallet AI, Christophers E, Schroder JM: IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy, J Immunol, 160: 60-68, 1998. |
| SSID | ssib004001968 ssib058494216 ssj0003236072 |
| Score | 1.6076046 |
| SecondaryResourceType | review_article |
| SourceID | nii jstage |
| SourceType | Publisher |
| StartPage | 79 |
| Title | Chemokines in Allergy |
| URI | https://www.jstage.jst.go.jp/article/jscc1971b/33/2/33_79/_article/-char/en https://cir.nii.ac.jp/crid/1390001204910025600 |
| Volume | 33 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Japanese Journal of Clinical Chemistry, 2004/06/30, Vol.33(2), pp.79-89 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZNeumlNCSlaZOyh-i0eGs9rAc9bReHkNJCIYHcjPXY4g1sQrq99NdnxpYdL0np4yKM5Jc88uibkb4ZQk4EruaCzstcoVwmdVSZVYXLlnUAeygE6Zfo0P_yVZ1dyvOr4qrP4Z7YJRs387-e5JX8j1ShDuSKLNl_kOxwU6iAY5AvlCBhKP9Kxsj2v7nGjeut2wJZfd-3lmnPYSrEFJPTEe5c9FzIRZ_rbVC66FWYzq-bu0FX09JQs6BG0bKgpqT2dEpLS-d5WyXpJ2jOtzwHDz7D9uHDttDfPznxqnSeFaoLVzGLbR3gAg2WZ0rAkvRoOqMZmbOdUuyyxfTTq31ScUvLW839w3tmNXMzIWa86q_cCoiNC3C5EAUmF9whz7nWDPdyfv5mxoqJjYL-AMiysg9ShFO04ELlulthSr1LhCp8jw-P3gLgyQrAOkZh2Fk3zQiBXLwiL5MIJ_NuHOyRZ6t6nxw8jIFJs56kMXBALk_Li8VZllJdZCvAXJtMCC-WGtAUN8bUuYlhKVXtChaZMzIEa31QGIwvesGUFw4mByl4ZLx2MhRRvCa765t1fEMmAQAz46C7AdxJy0ytDEZxc8rB1THyQ_Kx60t128UzqdL4rYZuV0JUHAtth0YkAcI_d0iO4QNUvsESrIfWkwlWJkvg-e0f2t-RF93eJ3RiHZHdzd3PeAywbuPetyK8BzrNPhI |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chemokines+in+Allergy&rft.jtitle=Japanese+Journal+of+Clinical+Chemistry&rft.au=Kanda+Akira&rft.au=%E8%8C%86%E5%8E%9F+%E9%A0%86%E4%B8%80&rft.date=2004&rft.pub=Japan+Society+of+Clinical+Chemistry&rft.issn=0370-5633&rft.eissn=2187-4077&rft.volume=33&rft.issue=2&rft.spage=79&rft.epage=89&rft_id=info:doi/10.14921%2Fjscc1971b.33.2_79&rft.externalDocID=130003357135 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0370-5633&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0370-5633&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0370-5633&client=summon |